# Cytosolix, Inc. — Form D

Cytosolix, Inc. of TOLLAND, CT, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-28. The offering totals $6.6M, of which $6.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-06-28
- Form: D
- Accession: 0001980943-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.6M
- Amount sold: $6.6M
- Investors: 12
- Date of first sale: 2023-06-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-485381

## Issuer

- Name: Cytosolix, Inc.
- CIK: 0001980943
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 97 ROBBIE ROAD, TOLLAND, CT, 06084
- Phone: (203) 606-5077

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Alex J Brunicki | Director | London, X0 |
| John J Deacon | Director | Tolland, CT |
| Colin J Foster | Director | Tolland, CT |
| Jason J Whitmire | Director | Berlin, 2M |
| John J Deacon | Executive Officer | Tolland, CT |
| Colin J Foster | Executive Officer | Tolland, CT |

## More

- [CIK 1980943 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1980943&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001980943-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.